Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 3, 2023
[Drug discovery research using AI and data science: analyzing literature information to understand pathological mechanisms]
Katsura Nozawa, Kazuhisa Tsunoyama
Journal of Chemical Information and Modeling
|
April 17, 2010
Are there differences between launched drugs, clinical candidates, and commercially available compounds?
Kazuki Ohno, Yuichi Nagahara, Kazuhisa Tsunoyama, et al.
Journal of Chemical Information and Modeling
|
May 7, 2008
Scaffold hopping in drug discovery using inductive logic programming
Kazuhisa Tsunoyama, Ata Amini, Michael J E Sternberg, et al.
Expert Opinion on Drug Discovery
|
November 6, 2012
Agreement of drug discovery data with Benford's law
Masaya Orita, Yosuke Hagiwara, Ayako Moritomo, et al.
Oncogene
|
September 20, 2022
ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer
Masayuki Komatsu, Hitoshi Ichikawa, Fumiko Chiwaki, et al.
Biochimica Et Biophysica Acta
|
August 12, 2014
Antibody informatics for drug discovery
Hiroki Shirai, Catherine Prades, Randi Vita, et al.
Diabetologia
|
September 29, 2025
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function
Lindsey B Lamarche, Christopher Koch, Shareef Khalid, et al.
Nature Metabolism
|
September 26, 2024
Identification and characterization of human GDF15 knockouts
Allan M Gurtan, Shareef Khalid, Christopher Koch, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 3, 2023
[Drug discovery research using AI and data science: analyzing literature information to understand pathological mechanisms]
Katsura Nozawa, Kazuhisa Tsunoyama
Journal of Chemical Information and Modeling
|
April 17, 2010
Are there differences between launched drugs, clinical candidates, and commercially available compounds?
Kazuki Ohno, Yuichi Nagahara, Kazuhisa Tsunoyama, et al.
Journal of Chemical Information and Modeling
|
May 7, 2008
Scaffold hopping in drug discovery using inductive logic programming
Kazuhisa Tsunoyama, Ata Amini, Michael J E Sternberg, et al.
Expert Opinion on Drug Discovery
|
November 6, 2012
Agreement of drug discovery data with Benford's law
Masaya Orita, Yosuke Hagiwara, Ayako Moritomo, et al.
Oncogene
|
September 20, 2022
ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer
Masayuki Komatsu, Hitoshi Ichikawa, Fumiko Chiwaki, et al.
Biochimica Et Biophysica Acta
|
August 12, 2014
Antibody informatics for drug discovery
Hiroki Shirai, Catherine Prades, Randi Vita, et al.
Diabetologia
|
September 29, 2025
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function
Lindsey B Lamarche, Christopher Koch, Shareef Khalid, et al.
Nature Metabolism
|
September 26, 2024
Identification and characterization of human GDF15 knockouts
Allan M Gurtan, Shareef Khalid, Christopher Koch, et al.
Page
of 1